International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064

Downloads: 6 | Views: 30 | Weekly Hits: ⮙6 | Monthly Hits: ⮙6

Research Paper | Medical Science | India | Volume 13 Issue 7, July 2024 | Rating: 6.1 / 10


Phenotypic and Molecular Characterization of Multidrug - Resistant Uropathogenic Escherichia coli

Sonowal T | Shariff M


Abstract: Background: Urinary tract infection (UTI) is the second most common infection after respiratory tract infections in the community. In hospitals, UTI accounts for approximately 35% of all hospital - acquired illnesses. Uropathogenic E. coli (UPEC) accounts for 70%. Increased rates of MDR isolates of E. coli make it a difficult - to - treat pathogen. Materials & Methods: UPEC isolates confirmed by MALDI - TOF were included in the study. The isolates were tested for antibiotic sensitivity to different antimicrobials, and the production of Beta - lactamases viz. ESBL, MBL, and AmpC by phenotypic and genotypic assays. Their clonality was determined by the RAPD. Results: Out of 1150 urinary samples, 122 yielded pathogens, of which 55 were E. coli. Twenty - nine (52.7%) multi - drug resistant isolates were tested for beta - lactamases. All (29) isolates were positive for ESBL, and 6 isolates also harboured MBL genes by PCR. None of the isolates produced AmpC. OXA (n=21) was the commonest followed by TEM and SHV. Among the MBLs, SPM, GIM, IMP, and VIM were detected. Thirteen isolates had Multiple types of beta - lactamase genes. Conclusion: 53 per cent of our E. coli isolates were MDR. All of them produced beta - lactamases. Hence, routine ESBL testing for uropathogens would be useful for all cases of UTI.


Keywords: Beta - lactamase; ESBL; Multidrug resistance; RAPD; uropathogenic Escherichia coli


Edition: Volume 13 Issue 7, July 2024,


Pages: 605 - 611

Rate this Article


Select Rating (Lowest: 1, Highest: 10)

5

Your Comments

Characters: 0


Type Your Registered Email Address below to Rate the Article


Verification Code will appear in 2 Seconds ... Wait

Top